[ad#PhycoBiosciences AIM Interview]

Money

Euglena soaring on Japanese stock exchange

May 20, 2013
AlgaeIndustryMagazine.com

Kengo Suzuki, head of Research and Development at Euglena Co., works in the company's laboratory in Tokyo. Euglena, a venture formed by the University of Tokyo, has soared 10-fold this year for the second-best performance on the Tokyo Stock Exchange Mothers Index.

Kengo Suzuki, head of Research and Development at Euglena Co., works in the company’s laboratory in Tokyo. Euglena, a venture formed by the University of Tokyo, has soared 10-fold this year for the second-best performance on the Tokyo Stock Exchange Mothers Index. Photographer: Tomohiro Ohsumi/Bloomberg

Satoshi Kawano & Kanoko Matsuyama report for Bloomberg.com that a Japanese biotech venture focused on making jet fuel from algae is soaring in Tokyo trading as cash being pumped into the economy by the central bank cascades into speculative investments.

“The market expects quantitative and qualitative easing to continue long term, boosting liquidity and drawing investors to speculative shares like biotech,” said Kazuyuki Terao, chief investment officer at Allianz Global Investors Japan.

Euglena, a venture formed by the University of Tokyo, has soared 10-fold this year for the second-best performance on the Tokyo Stock Exchange Mothers Index. The company is developing single-cell algae based products including jet fuel, which it expects to supply steadily by 2018, its President, Mitsuru Izumo, said in an interview.

The venture is currently valued at about 157 billion yen (15.35 million USD) and trades at about 335 times forecast earnings. Still, Japan’s fastest-rising biotech companies have yet to produce steady profit, so the investors’ bets are speculative, said Terao of Allianz Global.

The JASDAQ index had an average price earnings ratio of about 22, based on analyst estimates for the year, while the Tokyo Stock Exchange Mother’s Index, which includes Euglena, averaged about 74 times earnings estimated by analysts, according to data compiled by Bloomberg.

The multiples for many of the companies aren’t prohibitively high, said Tomohiko Ikeno, an analyst at Ace Research Institute. “It is still a good time to invest in some Japanese biotech ventures to hold long term,” Ikeno said. “The stocks will be volatile in the short term, but still have great potential for gains.”

Read More

More Like This…

HOME Algae Industry Jobs

Copyright ©2010-2013 AlgaeIndustryMagazine.com. All rights reserved. Permission granted to reprint this article in its entirety. Must include copyright statement and live hyperlinks. Contact editorial@algaeindustrymagazine.com. A.I.M. accepts unsolicited manuscripts for consideration, and takes no responsibility for the validity of claims made in submitted editorial.

From The A.I.M. Archives

— Refresh Page for More Choices
James “Jamie” Levine took over the reigns at Sapphire Energy in July of this year as former President and CEO Cynthia “CJ” Warner stepped down, retaining her role as chai...
Green Star Products, Inc. (GSPI) has signed a contract to build a demonstration facility in Las Vegas, Nevada, to produce commercial quality algae. The Hybrid Algae Produ...
Using a malaria parasite protein produced from algae, paired with an immune-boosting cocktail suitable for use in humans, researchers at UC San Diego School of Medicine g...
As one of the most water-poor countries in the world, Jordan’s current water resources are significantly below the global water scarcity line. Annual rainfall falls under...
Sebastian Rich reports on PBS Newshour about the Central African Republic city of Bangui, which has been caught in the crossfire between warring Muslim and Christian grou...
Natacha Tatu writes in Worldcrunch about a 72-year old French chef who has taken on the challenge of bringing spirulina to the malnourished youth of the Central Africa. F...
Scientists have been investigating the likely future impact of changing environmental conditions on ocean phytoplankton, which forms the basis of all the oceans' food cha...
Mark Harris writes in the Guardian about a pilot project in Las Cruces, New Mexico, where Dr. Peter Lammers, a professor in algal bioenergy at Arizona State University, a...
DENSO Corporation, Toyota Motor Corp.’s largest supplier, has announced that it will build a large test facility to culture Pseudochoricystis ellipsoidea – an oil-produci...
Algatechnologies Ltd. has launched its AstaPure® 5% Natural Astaxanthin oleoresin, derived from Haematococcus pluvialis microalgae. This latest addition to the AstaPure f...
Algae.Tec has announced that it has completed the commissioning and initial startup of an algae production plant to produce algae-based nutraceutical products. The plant ...
The Algae and Biofuels Laboratory at the University of Kentucky Center for Applied Energy Research (CAER) is partnering with Lianhenghui Investment Company to construct a...